These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 28133878)

  • 1. Acne RA-1,2, a novel UV-selective face cream for patients with acne: Efficacy and tolerability results of a randomized, placebo-controlled clinical study.
    Cestone E; Michelotti A; Zanoletti V; Zanardi A; Mantegazza R; Dossena M
    J Cosmet Dermatol; 2017 Jun; 16(2):265-270. PubMed ID: 28133878
    [TBL] [Abstract][Full Text] [Related]  

  • 2. UV-selective face cream (Acne RA-1,2) in acne patients: clinical study of its effects on epidermal barrier function, sebum production, tolerability and therapy adherence.
    Monfrecola G; Capasso C; Russo G; Fabbrocini G
    G Ital Dermatol Venereol; 2018 Feb; 153(1):26-32. PubMed ID: 27284780
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Double-blind, randomized, placebo-controlled study of a lotion containing triethyl citrate and ethyl linoleate in the treatment of acne vulgaris.
    Charakida A; Charakida M; Chu AC
    Br J Dermatol; 2007 Sep; 157(3):569-74. PubMed ID: 17635508
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Topical epidermal growth factor for the improvement of acne lesions: a randomized, double-blinded, placebo-controlled, split-face trial.
    Kim HK; Yeo IK; Li K; Kim BJ; Kim MN; Hong CK
    Int J Dermatol; 2014 Aug; 53(8):1031-6. PubMed ID: 24962549
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Randomized phase 3 evaluation of trifarotene 50 μg/g cream treatment of moderate facial and truncal acne.
    Tan J; Thiboutot D; Popp G; Gooderham M; Lynde C; Del Rosso J; Weiss J; Blume-Peytavi U; Weglovska J; Johnson S; Parish L; Witkowska D; Sanchez Colon N; Alió Saenz A; Ahmad F; Graeber M; Stein Gold L
    J Am Acad Dermatol; 2019 Jun; 80(6):1691-1699. PubMed ID: 30802558
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improved efficacy and tolerability of retinoic acid in acne vulgaris: a new topical formulation with cyclodextrin complex psi.
    Anadolu RY; Sen T; Tarimci N; Birol A; Erdem C
    J Eur Acad Dermatol Venereol; 2004 Jul; 18(4):416-21. PubMed ID: 15196153
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety and efficacy of two anti-acne/anti-aging treatments in subjects with photodamaged skin and mild to moderate acne vulgaris.
    Kircik LH; Dahl A; Yatskayer M; Raab S; Oresajo C
    J Drugs Dermatol; 2012 Jun; 11(6):737-40. PubMed ID: 22648221
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reducing the oral isotretinoin skin side effects: efficacy of 8% omega-ceramides, hydrophilic sugars, 5% niacinamide cream compound in acne patients.
    Cannizzaro MV; Dattola A; Garofalo V; Del Duca E; Bianchi L
    G Ital Dermatol Venereol; 2018 Apr; 153(2):161-164. PubMed ID: 29564872
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term safety and efficacy of trifarotene 50 μg/g cream, a first-in-class RAR-γ selective topical retinoid, in patients with moderate facial and truncal acne.
    Blume-Peytavi U; Fowler J; Kemény L; Draelos Z; Cook-Bolden F; Dirschka T; Eichenfield L; Graeber M; Ahmad F; Alió Saenz A; Rich P; Tanghetti E
    J Eur Acad Dermatol Venereol; 2020 Jan; 34(1):166-173. PubMed ID: 31306527
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A pilot study on efficacy treatment of acne vulgaris using a new method: results of a randomized double-blind trial with Acne Dressing.
    Chao CM; Lai WY; Wu BY; Chang HC; Huang WS; Chen YF
    J Cosmet Sci; 2006; 57(2):95-105. PubMed ID: 16688374
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of tazarotene 0.1 % cream in the treatment of facial acne vulgaris: pooled results from two multicenter, double-blind, randomized, vehicle-controlled, parallel-group trials.
    Shalita AR; Berson DS; Thiboutot DM; Leyden JJ; Parizadeh D; Sefton J; Walker PS; Gibson JR;
    Clin Ther; 2004 Nov; 26(11):1865-73. PubMed ID: 15639698
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Specific gel-cream as adjuvant to oral isotretinoin improved hydration and prevented TEWL increase--a double-blind, randomized, placebo-controlled study.
    Herane MI; Fuenzalida H; Zegpi E; De Pablo C; Espadas MJ; Trullás C; Mirada A; Martin GG
    J Cosmet Dermatol; 2009 Sep; 8(3):181-5. PubMed ID: 19735515
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of silicol gel compared with placebo on papulopustular acne and sebum production. A double-blind study.
    Lassus A
    J Int Med Res; 1996; 24(4):340-4. PubMed ID: 8854287
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Moderate and Severe Inflammatory Acne Vulgaris Effectively Treated with Single-Agent Therapy by a New Fixed-Dose Combination Adapalene 0.3 %/Benzoyl Peroxide 2.5 % Gel: A Randomized, Double-Blind, Parallel-Group, Controlled Study.
    Stein Gold L; Weiss J; Rueda MJ; Liu H; Tanghetti E
    Am J Clin Dermatol; 2016 Jun; 17(3):293-303. PubMed ID: 26945741
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A double-blind, randomized, vehicle-controlled efficacy assessment study of a skin care formulation for improvement of mild to moderately severe acne.
    Angelova-Fischer I; Rippke F; Fischer TW; Neufang G; Zillikens D
    J Eur Acad Dermatol Venereol; 2013 Jul; 27 Suppl 2():6-11. PubMed ID: 23731195
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The efficacy and tolerability of tazarotene foam, 0.1%, in the treatment of acne vulgaris in 2 multicenter, randomized, vehicle-controlled, double-blind studies.
    Feldman SR; Werner CP; Alió Saenz AB
    J Drugs Dermatol; 2013 Apr; 12(4):438-46. PubMed ID: 23652892
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of a daily facial cleanser for normal to oily skin on the skin barrier of subjects with acne.
    Draelos ZD
    Cutis; 2006 Jul; 78(1 Suppl):34-40. PubMed ID: 16910029
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A double-blind, randomized, bilateral comparison of skin irritancy following application of the combination acne products clindamycin/tretinoin and benzoyl peroxide/adapalene.
    Goreshi R; Samrao A; Ehst BD
    J Drugs Dermatol; 2012 Dec; 11(12):1422-6. PubMed ID: 23377511
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety and efficacy of clindamycin phosphate 1.2%-benzoyl peroxide 3% fixed-dose combination gel for the treatment of acne vulgaris: a phase 3, multicenter, randomized, double-blind, active- and vehicle-controlled study.
    Eichenfield LF; Alió Sáenz AB
    J Drugs Dermatol; 2011 Dec; 10(12):1382-96. PubMed ID: 22134562
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combination therapy with adapalene-benzoyl peroxide and oral lymecycline in the treatment of moderate to severe acne vulgaris: a multicentre, randomized, double-blind controlled study.
    Dréno B; Kaufmann R; Talarico S; Torres Lozada V; Rodríguez-Castellanos MA; Gómez-Flores M; De Maubeuge J; Berg M; Foley P; Sysa-Jedrzejowska A; Kerrouche N; Paliargues F; Bettoli V
    Br J Dermatol; 2011 Aug; 165(2):383-90. PubMed ID: 21495995
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.